loader

hls:cc

LATEST ARTICLES

HLS Therapeutics Increases Normal Course Issuer Bid

HLS Therapeutics Announces Q2 2026 Financial Results

HLS Therapeutics Provides Update on NILEMDO Market Access

HLS Therapeutics to Host Q2 2026 Financial Results Conference Call

HLS Therapeutics Reports Annual Meeting Results

HLS Therapeutics Announces Normal Course Issuer Bid

HLS Therapeutics Announces Q1 2026 Financial Results

HLS Therapeutics to Host Q1 2026 Financial Results Conference Call

HLS Therapeutics to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

HLS Therapeutics Announces Fiscal 2025 Financial Results

HLS Therapeutics Announces NILEMDOTM is now available in Canada for the Reduction of LDL-Cholesterol in Patients at Risk of Cardiovascular Disease

HLS Therapeutics to Host Fiscal 2025 Financial Results Conference Call

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES